|Mr. Uwe Zimdars||CEO & Member of the Exec. Board||N/A||N/A||N/A|
|Mr. Daniel Kracht||CFO & Member of the Exec. Board||N/A||N/A||N/A|
HAEMATO AG, together with its subsidiaries, operates in the pharmaceutical sector in Germany. The company distributes European import medicinal products; and manufactures and distributes its own generic medicinal products. It provides pharmaceuticals in the areas of oncology, HIV, rheumatism, neurology, and cardiovascular diseases; and products for aesthetic treatments. The company also develops and commercializes pharmaceutical, medicinal, and medical engineering products for aesthetic surgery and cosmetic dermatology. It serves wholesalers and pharmacies, as well as doctors and hospitals. The company was founded in 1993 and is based in Schönefeld, Germany. HAEMATO AG is a subsidiary of MPH Health Care AG.
HAEMATO AG’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.